Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancer.
Phase of Trial: Phase I
Latest Information Update: 12 May 2016
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 15 Apr 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 15 Jan 2008 New trial record.